http://silico.wordpress.com/about/ 2009-01-13T14:25:51+00:00 weekly 0.6 http://silico.wordpress.com/about/client-assignments/ 2009-07-23T18:06:04+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/ 2009-11-30T19:41:45+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/pfizer/ 2009-10-16T11:20:53+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/merck-co/ 2009-10-16T11:22:02+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/glaxosmithkline/ 2009-10-16T11:23:54+00:00 weekly 0.6 http://silico.wordpress.com/partnering-research/ 2009-10-16T12:35:52+00:00 weekly 0.6 http://silico.wordpress.com/partnering-research/trust-and-alliance-metrics/ 2009-10-16T11:32:01+00:00 weekly 0.6 http://silico.wordpress.com/partnering-research/social-network-analysis/ 2009-10-19T19:10:34+00:00 weekly 0.6 http://silico.wordpress.com/partnering-research/alliance-failure-rates/ 2009-10-16T11:35:46+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/astrazeneca/ 2009-10-19T13:12:25+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/novartis-2/ 2009-11-11T14:29:14+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/partnering-profile-amgen/ 2009-11-19T15:55:10+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/bristol-myers-squibb/ 2009-11-26T14:05:10+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/sanofi-aventis/ 2009-11-30T14:36:17+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/eli-lilly/ 2009-11-30T14:41:35+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/daiichi-sankyo/ 2009-12-03T11:19:35+00:00 weekly 0.6 http://silico.wordpress.com/partnering-profiles/eisai/ 2009-12-03T16:13:09+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/07/biotechnology-accounts-for-17-of-eu-economy/ 2008-11-14T14:27:13+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/the-impact-of-alliances-on-share-prices/ 2008-11-06T10:49:55+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/the-key-drivers-of-alliance-formation/ 2008-11-06T11:08:44+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/the-impact-of-conditional-payment-mechanisms-on-alliance-outcomes/ 2008-11-06T11:19:36+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/nda-applications-continue-to-decline-in-2006/ 2008-11-14T14:10:32+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/india-and-chinas-biogeneric-and-vaccine-strengths/ 2008-11-14T12:42:09+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/pension-funds-highlight-the-importance-of-collaboration-to-pharmaceutical-companies/ 2008-11-14T12:24:35+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/merck-kgaa-acquires-serono-for-us135-billion/ 2008-11-06T13:38:35+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/india-and-chinas-place-in-biotechnology-innovation/ 2008-11-06T13:44:01+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/pfizer-streamlines-research-to-prepare-for-post-lipitor-world/ 2008-11-14T13:46:20+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/meda-buys-wyeth-treatments/ 2008-11-14T13:58:27+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/09/tykerbs-implications-for-partnerships/ 2008-11-06T17:56:11+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/11/chinas-biopharmaceutical-patent-footprint/ 2008-11-06T13:24:00+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/11/glaxosmithkline-announces-chinese-neurology-research-centre/ 2008-11-14T14:06:58+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/16/johnson-johnson-turns-to-internal-venturing/ 2008-11-14T14:02:20+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/25/south-koreas-biopharmaceutical-patent-footprint-a-year-on-from-hwang/ 2008-11-06T10:16:56+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/25/astrazenecas-acquisition-of-medimmune/ 2008-11-06T17:49:16+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/25/biotechnology-beyond-the-us/ 2008-11-06T10:42:08+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/25/biopharmaceutical-partnering-in-china/ 2008-11-06T17:51:11+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/25/hedge-funds-get-a-taste-for-biotechnology-companies/ 2008-11-06T13:58:36+00:00 weekly 0.6 http://silico.wordpress.com/2007/07/27/amgen-tries-its-hand-at-venture-capital/ 2009-03-02T12:49:09+00:00 weekly 0.6 http://silico.wordpress.com/2007/08/31/joint-ownership-of-patents-inhibits-licensing-deals/ 2008-11-14T11:39:57+00:00 weekly 0.6 http://silico.wordpress.com/2007/08/31/novartis-switching-planned-research-investments-from-india-to-china/ 2008-11-14T11:42:37+00:00 weekly 0.6 http://silico.wordpress.com/2007/09/01/learning-from-game-theory/ 2008-11-06T11:25:13+00:00 weekly 0.6 http://silico.wordpress.com/2007/09/06/balancing-control-and-trust-in-alliances/ 2008-11-06T12:46:04+00:00 weekly 0.6 http://silico.wordpress.com/2007/09/14/bristol-myers-squibb-expands-partnerships/ 2009-03-02T12:46:40+00:00 weekly 0.6 http://silico.wordpress.com/2007/09/21/big-hopes-from-small-technologies/ 2008-11-14T12:32:14+00:00 weekly 0.6 http://silico.wordpress.com/2007/09/28/takeda-flexes-its-partnering-muscles/ 2008-11-14T12:36:55+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/05/the-impact-of-cultural-factors-on-alliance-performance/ 2008-11-06T11:00:58+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/10/reducing-alliance-risks/ 2008-11-06T18:05:55+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/12/procter-and-gamble-relies-on-collaboration-to-drive-innovation/ 2008-11-06T13:05:21+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/12/ge-healthcare-alliances-in-the-medical-devices-and-diagnostic-market/ 2008-11-14T12:28:50+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/12/ge-and-lilly-ink-cancer-diagnostics-linkup/ 2008-11-06T14:10:34+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/15/using-balanced-scorecards-as-a-tool-for-partnership-analysis/ 2008-11-06T13:15:06+00:00 weekly 0.6 http://silico.wordpress.com/2007/10/21/cross-sector-collaboration-set-to-grow/ 2008-11-14T12:56:27+00:00 weekly 0.6 http://silico.wordpress.com/2007/11/01/yahoo-leads-amazon-google-and-ebay-in-patents-at-least/ 2008-11-14T11:48:51+00:00 weekly 0.6 http://silico.wordpress.com/2007/11/12/public-private-partnerships-for-drug-development-an-emerging-trend-or-special-cases-2/ 2008-11-14T11:25:54+00:00 weekly 0.6 http://silico.wordpress.com/2007/11/12/exubera-shows-the-importance-of-having-an-exit-strategy/ 2008-11-06T13:02:44+00:00 weekly 0.6 http://silico.wordpress.com/2007/11/20/are-universities-the-nations-scientific-powerhouse-or-little-more-than-costly-ivory-towers/ 2008-11-14T11:34:51+00:00 weekly 0.6 http://silico.wordpress.com/2008/01/04/latest-research-on-the-top-patent-lawyers/ 2008-11-14T11:56:53+00:00 weekly 0.6 http://silico.wordpress.com/2008/02/15/life-science-companies-optimistic-about-2008/ 2008-11-06T14:01:52+00:00 weekly 0.6 http://silico.wordpress.com/2008/04/04/pfizer-invests-in-web-based-software-company/ 2008-11-14T12:39:50+00:00 weekly 0.6 http://silico.wordpress.com/2008/04/08/the-impact-of-large-alliances-on-share-prices/ 2008-11-06T13:01:41+00:00 weekly 0.6 http://silico.wordpress.com/2008/04/08/funding-research-and-development-through-spin-outs/ 2008-11-14T13:42:50+00:00 weekly 0.6 http://silico.wordpress.com/2008/09/15/alliances-drive-the-hunt-for-clean-energy/ 2008-11-06T13:13:56+00:00 weekly 0.6 http://silico.wordpress.com/2008/09/15/biopartnering-2008/ 2008-11-06T18:06:40+00:00 weekly 0.6 http://silico.wordpress.com/2008/11/05/getting-to-the-bottom-of-alliance-failure-rates/ 2008-11-07T13:35:20+00:00 weekly 0.6 http://silico.wordpress.com/2008/11/11/partners-matter-to-nhs/ 2008-11-13T10:30:42+00:00 weekly 0.6 http://silico.wordpress.com/2008/11/13/the-risks-in-partnering/ 2008-11-14T12:45:28+00:00 weekly 0.6 http://silico.wordpress.com/2008/12/17/positioning-alliance-management/ 2008-12-17T11:46:53+00:00 weekly 0.6 http://silico.wordpress.com/2008/12/17/becoming-a-partner-of-choice/ 2008-12-17T11:54:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/01/15/google-ranked-most-attractive-technology-company/ 2009-01-27T10:14:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/01/27/is-the-a-halo-effect-in-partner-perception-surveys/ 2009-01-27T09:56:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/01/28/pfizer-buys-wyeth/ 2009-03-02T12:45:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/01/30/roche-bid-for-genentech-is-another-sign-of-confidence/ 2009-01-30T13:39:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/04/of-sheep-and-goats/ 2009-03-02T12:44:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/10/is-2009-going-to-be-a-good-year-for-alliances/ 2009-02-10T13:30:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/13/the-biotech-gloom-could-be-overdone/ 2009-02-17T10:42:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/19/why-venture-funding-is-still-going-into-biotech/ 2009-02-19T13:09:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/19/roche-beats-bond-record/ 2009-02-19T13:12:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/23/throw-away-all-that-pre-crisis-data/ 2009-02-24T10:53:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/24/alliance-failure-rates-revisted/ 2009-03-02T12:44:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/25/david-and-goliath-retold/ 2009-02-26T10:44:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/26/obamas-stimulus-package-to-boost-public-private-partnerships/ 2009-02-26T14:56:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/02/27/should-us-biotech-have-a-federal-bailout/ 2009-03-02T12:44:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/02/genentech-more-valuable-than-pfizer/ 2009-03-03T13:42:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/02/is-biopharma-a-buy/ 2009-03-02T12:43:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/03/pfizer-signs-generics-alliance/ 2009-03-03T11:27:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/03/pfizer-expects-to-be-biggest-pharma-in-japan/ 2009-03-03T11:29:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/03/biopharma-sentiment-takes-a-plunge/ 2009-03-04T11:48:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/04/banking-on-biotechnology/ 2009-03-04T11:45:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/04/pfizer-breaks-up-its-research-division/ 2009-03-04T14:50:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/04/bain-pushes-pooled-research/ 2009-03-05T09:29:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/05/pa-supercedes-ma/ 2009-03-05T09:32:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/05/ibm-report-on-life-science-alliances/ 2009-03-10T10:14:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/06/prfizer-and-sanofi-aventis-race-to-grab-wockhardt-stake/ 2009-03-06T11:02:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/08/buy-when-theres-blood-in-the-streets/ 2009-03-09T17:16:36+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/08/roche-ups-offer-for-genentech-to-93/ 2009-03-09T11:21:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/vc-financing/ 2009-03-09T11:20:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/merck-and-schering-plough-to-merge/ 2009-03-09T17:14:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/buying-spree-to-continue/ 2009-03-09T17:08:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/is-the-merck-deal-going-to-help-roche/ 2009-03-09T17:11:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/sanofi-aventis-swaps-partnerships/ 2009-03-09T18:13:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/09/nyt/ 2009-03-10T10:10:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/10/ibm-examines-life-science-alliances-with-academia/ 2009-03-10T16:31:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/10/biotech-generics-may-get-early-push/ 2009-03-10T16:32:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/10/597/ 2009-03-11T11:33:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/11/is-the-merckschering-merger-going-to-run-into-legal-problems/ 2009-03-11T11:35:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/11/mergers-kill-research/ 2009-03-11T11:36:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/11/pharma-take-on-eyewatering-breakup-fees-liabilities/ 2009-03-11T11:37:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/11/is-the-uk-biotechnology-sector-in-trouble/ 2009-03-11T18:14:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/12/roche-gets-over-the-line-with-genentech/ 2009-03-12T09:09:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/12/moodys-cuts-pfizers-rating/ 2009-03-16T10:21:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/12/astellas-scraps-agreement-with-neurosearch/ 2009-03-16T10:22:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/13/gilead-beats-astellas-to-cv-therapeutics/ 2009-03-13T09:08:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/13/details-of-jj-cancellation-rights-emerge/ 2009-03-16T10:24:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/13/ceos-turn-to-alliances-to-weather-the-storm/ 2009-03-16T10:25:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/13/glaxosmithkline-signs-generics-agreement-with-prasco-laboratories/ 2009-03-16T10:25:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/16/merck-serono-creates-early-stage-fund/ 2009-03-16T10:28:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/16/pwc-collaboration-report/ 2009-03-16T12:25:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/16/astellas-drops-bid-for-cv-therapeutics/ 2009-03-16T12:27:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/16/technology-executives-seek-alliances-to-survive-economic-downturn/ 2009-03-16T12:56:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/16/hewlett-packard-and-sun-microsystems-enter-server-alliance/ 2009-03-16T13:09:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/17/exploring-johnson-johnsons-options/ 2009-03-17T10:58:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/17/pfizer-may-get-lower-rates-than-roche/ 2009-03-17T11:03:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/17/japanese-sit-out-the-mergerfest/ 2009-03-18T12:08:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/18/new-standards-reached-in-the-death-of-biotechnology-hype/ 2009-03-18T12:54:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/19/uk/ 2009-03-19T11:24:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/20/bayer-invests-in-chinese-research/ 2009-03-20T12:27:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/20/dyaxs-cost-of-money-is-2150/ 2009-03-23T13:05:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/23/are-licensing-up-front-fees-set-to-fall/ 2009-03-23T09:57:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/23/merck-serono-releases-details-about-its-venture-fund/ 2009-03-23T10:08:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/24/nycomed-up-for-sale/ 2009-03-24T16:29:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/24/cisco-and-emc-expand-data-centre-alliance/ 2009-03-24T16:30:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/26/vodafone-and-telefonica-agree-to-share-networks/ 2009-03-26T13:14:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/26/cold-water-poured-on-corporate-venturing/ 2009-03-26T13:16:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/elan-in-the-crosshairs/ 2009-03-27T13:16:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/cisco-and-ibm-tap-partners-for-acquisitions/ 2009-03-27T13:57:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/the-motley-fool-casts-doubt-on-pharma-mega-mergers/ 2009-03-27T13:59:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/at-least-pharma-ma-bankers-are-hiring/ 2009-03-27T14:00:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/wsj-finds-out-how-to-get-money-for-biotech-projects/ 2009-03-27T17:00:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/27/taiwanese-set-sights-on-biotechnology/ 2009-03-31T08:56:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/31/lilly-ceo-resists-mega-mergers/ 2009-03-31T08:40:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/31/ibm-and-cisco-form-cloud-alliance/ 2009-03-31T09:00:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/31/takeda-moves-rd-from-osaka-to-chicago/ 2009-03-31T12:47:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/03/31/jj-looks-to-extract-leverage-from-merckschering-plough-merger/ 2009-03-31T16:30:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/02/alliances-in-the-wake-of-obamas-comparative-effectiveness-center/ 2009-04-03T08:54:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/02/bayers-transfers-cancer-drugs-to-genzyme/ 2009-04-02T09:28:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/02/partnering-now-accounts-for-23-of-biotechnology-funding/ 2009-04-02T12:27:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/03/pressure-to-speed-up-approval-of-generic-biologic-drugs/ 2009-04-03T09:20:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/03/ge-and-intel-to-form-healthcare-alliance/ 2009-04-07T13:29:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/06/ft-profiles-john-lechleiter/ 2009-04-07T13:30:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/06/bms-extends-abilify-deal-with-otsuka/ 2009-04-07T13:32:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/16/spinning-failure/ 2009-04-16T20:06:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/16/astrazeneca-passes-on-mega-mergers/ 2009-04-16T20:09:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/16/pfizer-and-gsk-form-hiv-joing-venture/ 2009-04-16T18:43:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/20/oracle-buys-sun-for-740-billion/ 2009-04-21T12:23:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/20/ibm-samsung-sign-chip-alliance/ 2009-04-21T12:23:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/20/pharmacyclics-announces-alliance-with-les-laboratoires-servier/ 2009-04-21T12:25:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/20/merck-and-galapagos-sign-inflammatory-alliance/ 2009-04-21T12:26:12+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/21/862/ 2009-04-23T12:00:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/22/864/ 2009-04-22T15:09:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/22/fujitsu-and-cisco-expand-strategic-alliance/ 2009-04-23T11:09:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/22/reducing-alliance-management-metrics-to-meaninglessness/ 2009-04-23T11:11:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/22/british-government-pours-money-into-biotechnology-and-technology/ 2009-04-22T15:37:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/24/merck-signs-performance-related-deal-with-cigna/ 2009-04-27T10:08:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/24/elan-seeking-a-partnership/ 2009-04-27T10:07:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/27/half-of-it-solution-providers-regret-joining-partner-programs/ 2009-04-27T15:24:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/27/pfizer-and-ucl-announce-stem-cell-collaboration/ 2009-04-27T15:48:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/30/sanofi-and-oxford-biomedia-redraw-alliance/ 2009-04-30T19:25:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/04/30/imquest-biosciences-and-arisyn-therapeutics-announce-strategic-partnership/ 2009-04-30T19:26:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/01/research-from-an-alliance-provides-possible-solution-to-flu-pandemics/ 2009-05-01T17:21:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/01/is-the-pharmaceutical-industry-evolving-towards-a-neworked-health-management-model/ 2009-05-06T10:55:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/05/acadia-signs-395-million-partnership-with-biovail/ 2009-05-06T10:56:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/05/sanofi-sets-up-biotechnology-incubator/ 2009-05-06T10:57:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/06/pharmaimage-2009/ 2009-05-06T09:51:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/06/bristol-myers-squibb-looking-to-acquire-small-biotechnology-companies/ 2009-05-06T15:12:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/06/citrix-sees-partners-as-key/ 2009-05-07T11:53:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/07/combinatorx-announces-oncology-collaboration-with-novartis/ 2009-05-07T11:19:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/07/evotec-retrenches-and-concentrates-on-alliances/ 2009-05-07T11:47:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/07/takeda-and-eli-lilly-led-biotechnology-acquisitions-in-2008/ 2009-05-07T11:52:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/07/alliance-to-develop-vaccine-for-h1n1-flu/ 2009-05-07T12:16:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/08/boehringer-ingelheim-partners-with-exelixis/ 2009-05-08T15:33:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/08/paladin-labs-and-isotechnika-partner-to-develop-voclosporin/ 2009-05-08T15:31:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/11/eisai-threatens-to-terminate-aricept-agreement-with-pfizer/ 2009-05-11T11:27:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/12/roche-partners-with-tekmira-pharmaceuticals/ 2009-05-12T10:31:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/12/antisoma-sells-rights-to-oral-fludarabine-to-sanofi-aventis/ 2009-05-12T17:29:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/13/gsk-extends-relationship-with-aspen/ 2009-05-13T09:10:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/13/exelixis-and-boehringer-ingelheim-partners-for-autoimmune-diseases/ 2009-05-13T16:17:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/13/china-invests-in-biotechnology-and-technology/ 2009-05-13T16:47:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/14/boehringer-ingelheim-and-develogen-ag-announce-agreement/ 2009-05-14T13:03:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/15/uk-financial-services-cool-on-alliances/ 2009-05-15T10:40:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/15/huya-bioscience-international-ties-up-with-abbott/ 2009-05-15T13:33:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/15/sanofi-aventis-and-kyowa-hakko-kirin-partner-in-human-monoclonal-antibodies/ 2009-05-15T14:13:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/18/avalon-terminates-alliance-with-merck/ 2009-05-18T13:13:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/18/oxford-biotherapeutics-partners-with-glaxosmithkline/ 2009-05-18T13:52:12+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/18/cancer-alliance-between-celgene-and-globeimmune/ 2009-05-18T13:48:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/19/solvay-pharmaceuticals-allies-with-huya-for-new-chinese-drug-candidates/ 2009-05-19T10:43:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/19/legal-dispute-between-onyx-pharmaceuticals-and-bayer-corporation/ 2009-05-19T10:54:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/19/electronics-health-records-a-rallying-point-for-alliances/ 2009-05-22T10:45:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/20/glaxosmithkline-pays-milestone-fee-to-regulus-therapeutics/ 2009-05-21T09:47:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/20/cardiome-partners-with-merck-co/ 2009-05-20T10:50:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/20/licensing-agreement-between-symbio-pharmaceuticals-eisai/ 2009-05-21T09:46:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/20/the-partnership-of-giants-in-diabetes-care/ 2009-05-20T14:00:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/johnson-johnson-goes-to-arbitration-to-end-schering-remicade-deal/ 2009-05-21T09:01:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/hamner-institute-and-china-medical-city-building-bridges-between-china-and-the-usa/ 2009-05-21T10:53:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/changes-to-alliance-agreement-between-schering-plough-and-novartis/ 2009-05-21T09:45:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/roche-and-moksha8-expand-commercialisation-partnership/ 2009-05-21T09:39:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/alliance-between-odyssey-thera-and-mitsubishi-tanabe-pharma/ 2009-05-21T09:44:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/alliance-between-aska-research-and-clinical-network-services/ 2009-05-21T10:30:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/monogram-biosciences-and-pfizer-extend-collaboration-for-assay/ 2009-05-21T10:39:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/21/distritbution-alliance-between-ziosoft-inc-and-mms-medicor-medical-supplies/ 2009-05-21T10:54:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/22/vernalis-and-servier-enter-oncology-alliance/ 2009-05-22T08:18:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/22/johnson-johnson-acquires-cougar-biotechnology/ 2009-05-22T09:26:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/22/merger-of-akela-pharma-and-nventa-biopharmaceuticals/ 2009-05-22T12:49:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/22/sanofi-aventis-potential-bid-for-quiagen/ 2009-05-22T12:51:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/22/alliance-between-china-sky-one-medical-and-golden-biotechnology-corporation/ 2009-05-22T13:00:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/symbio-and-eisai-sign-licencing-agreement/ 2009-05-26T08:21:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/kinemed-enters-into-collaboration-with-bristol-myers-squibb/ 2009-11-24T15:29:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/amri-earns-4-million-milestone-from-bms/ 2009-05-26T14:07:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/amgen-exercises-option-to-cytokinetics%e2%80%99-cardiac-contractility-program/ 2009-05-26T14:55:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/takeda-to-license-vaccine-for-haemophilus-influrnzae-type-b-from-novartis/ 2009-05-26T18:42:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/26/beactica-announces-drug-discovery-agreement-with-cubist-pharmaceuticals/ 2009-05-26T18:44:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/collaboration-front-and-centre-at-bio/ 2009-05-27T09:25:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/astrazeneca-sued-for-breach-of-collaboration-agreement/ 2009-05-27T10:13:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/sciele-acquires-global-rights-to-psd502-from-plethora-solutions/ 2009-05-27T10:24:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/anacor-announces-collaborations-with-tb-alliance-and-dndi/ 2009-05-27T14:48:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/gene-network-sciences-announces-collaboration-with-ucsf/ 2009-05-27T15:13:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/27/microsoft-announces-social-enterprise-alliance/ 2009-05-27T16:15:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/28/exelixis-and-sanofi-aventis-sign-global-license-agreement/ 2009-05-28T07:56:13+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/28/galapagos-earns-alliance-milestone-payment/ 2009-05-28T07:58:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/28/oft-investigates-gskpfizer-hiv-jv/ 2009-05-28T08:05:36+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/28/fujifilm-and-ge-healthcare-form-strategic-alliance-in-life-sciences/ 2009-05-28T14:45:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/28/raysearch-partners-with-siemens/ 2009-05-28T17:25:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/29/brocade-introduces-global-alliance-partner-network/ 2009-05-29T10:21:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/29/acs-and-novell-launch-strategic-partnership/ 2009-05-29T11:30:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/29/protea-announces-drug-development-partnership-with-mayoly-spindler/ 2009-05-29T13:49:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/29/mtm-laboratories-and-metasystems-partner-to-develop-imaging-system-partnership/ 2009-05-29T15:27:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/05/29/boehringer-ingelheim-and-dxs-sign-diagnostic-collaboration/ 2009-05-29T15:30:36+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/01/astrazeneca-and-merck-form-anticancer-collaboration/ 2009-06-02T09:56:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/01/symantec-shifting-partner-focus/ 2009-06-01T11:38:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/01/valeant-grants-schering-plough-exclusive-option-in-japan-for-taribavirin/ 2009-06-01T15:44:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/concert-pharmaceuticals-and-glaxosmithkline-in-1-billion-alliance/ 2009-06-02T08:55:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/protea-announces-drug-development-partnership-with-mayoly-spindler-2/ 2009-06-02T09:42:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/microsoft-partners-with-merck-co-for-genetic-data-management/ 2009-06-02T09:46:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/extol-and-valogix-enter-partnership/ 2009-06-02T09:52:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/cytori-and-ge-healthcare-alliance-for-stem-cell-technology/ 2009-06-02T10:05:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/02/gsk-partners-with-oxford-biotherapeutics/ 2009-07-01T11:11:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/03/gene-network-sciences-collaborates-with-university-of-connecticut/ 2009-06-03T13:15:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/03/epicept-announces-partnership-for-ceplene/ 2009-07-01T11:10:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/03/symbian-appoints-head-of-alliance-management/ 2009-06-03T14:36:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/04/novartis-announces-typhoid-vaccine-research-program-in-partnership-with-the-wellcome-trust/ 2009-06-04T15:53:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/08/eli-lilly-and-neurosearch-announce-alliance/ 2009-07-01T11:08:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/08/glaxo-novartis-roche-and-lilly-invest-in-aileron/ 2009-07-01T11:08:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/08/alder-expands-partnership-with-schering-plough/ 2009-06-08T15:42:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/08/astrazeneca-commits-4-million-to-cancer-research/ 2009-07-01T11:07:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/09/gsk-and-shenzhen-neptunus-create-influenza-jv/ 2009-07-01T11:06:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/09/huya-bioscience-announces-collaboration-with-the-shenyang-pharmaceutical-university/ 2009-07-01T11:06:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/09/elite-pharma-closes-alliance-with-epic-pharma/ 2009-07-01T11:05:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/09/1171/ 2009-07-01T11:05:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/10/astrazeneca-and-abbott-extend-partnership/ 2009-07-01T11:04:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/10/bayhill-therapeutics-sign-diabetes-collaboration-agreement-with-genentech/ 2009-07-01T11:03:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/10/roche-makes-4-25-milestone-payment-to-halozyme/ 2009-07-01T11:02:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/10/aposense-signs-agreement-with-glaxosmithkline/ 2009-07-01T11:01:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/11/xenon-enters-cardiovascular-disease-collaboration-with-merck/ 2009-07-01T11:01:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/11/1186/ 2009-07-01T10:59:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/11/1187/ 2009-07-01T10:58:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/11/merck-terminates-research-collaboration-with-neuromed/ 2009-07-01T10:57:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/12/pdx-and-rx-com-partner-with-microsofts-healthvault/ 2009-07-01T10:57:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/12/ibm-spends-2-50-billion-a-year-on-its-partner-ecosystem/ 2009-07-01T10:56:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/15/hemispherx-biopharma-and-biken-extend-flu-production-capacity/ 2009-06-15T09:18:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/15/synta-and-gsk-end-elesclomol-collaboration/ 2009-06-15T16:50:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/15/boehringer-ingelheim-and-vitae-pharmaceuticals-announce-alzheimers-collaboration/ 2009-07-01T10:53:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/15/dr-reddys-signs-partnership-with-glaxosmithkline/ 2009-07-01T10:53:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/16/ipsen-and-pharnext-partner/ 2009-07-01T10:51:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/16/morphosys-announces-extension-of-antibody-alliance-with-schering-plough/ 2009-07-01T10:51:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/16/cenix-bioscience-expands-relationship-with-astrazeneca/ 2009-07-01T10:50:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/17/arbitration-panel-reaffirms-biogen-idecs-contractual-right-under-collaboration-with-genentech/ 2009-07-01T10:50:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/17/covidien-announces-license-agreement-with-nuvo-research/ 2009-07-01T10:48:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/18/alcatel-lucent-hewlett-packard-sign-partnership-deal/ 2009-07-01T10:47:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/19/kv-pharmaceutical-enters-licensing-agreement-with-gedeon-richter/ 2009-07-01T10:45:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/19/astrazenecas-ceo-reiterates-the-importance-of-partnerships/ 2009-07-01T10:45:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/19/biotech-venture-funding-bounces-back/ 2009-07-01T10:44:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/22/access-pharmaceuticals-announces-two-new-evaluation-agreements/ 2009-06-22T09:45:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/22/cerep-and-servier-sign-new-collaboration/ 2009-07-01T10:42:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/22/cordex-signs-european-development-partnership-for-sperm-motility-drug/ 2009-07-01T10:34:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/23/wyeth-extends-collaboration-with-trubion/ 2009-07-01T10:32:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/23/merck-partners-with-dndi-to-tackle-neglected-diseases/ 2009-07-01T10:32:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/24/gsk-and-chroma-therapeutics-form-alliance-to-develop-novel-macrophage-targeted-drugs/ 2009-07-01T10:29:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/24/biomarin-sues-la-jolla-for-breach-of-partnership-agreement/ 2009-07-01T10:27:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/24/covagen-and-roche-sign-collaboration-agreement/ 2009-06-24T10:40:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/24/intel-and-nokia-announce-mobile-strategic-relationship/ 2009-06-24T10:45:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/24/samsung-electronics-and-numonyx-sign-semiconductor-alliance/ 2009-06-24T10:53:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/25/alliances-with-chinese-biopharma-companies-few-and-far-between/ 2009-07-01T10:23:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/25/new-boston-scientific-ceo-looks-to-increase-partnerships/ 2009-06-25T15:43:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/25/acusphere-announces-amended-agreement-with-cephalon/ 2009-07-01T10:21:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/25/cerulean-pharma-signs-license-agreement-with-calando-pharmaceuticals/ 2009-07-01T10:20:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/29/biocon-signs-biogeneric-alliance-with-mylan/ 2009-07-01T10:19:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/30/domainex-announces-academic-asthma-treatment-collaboration/ 2009-07-01T10:17:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/30/juvaris-biotherapeutics-signs-collaboration-agreement-with-antigen-discovery/ 2009-06-30T08:54:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/06/30/partnering-profiles-pfizer/ 2009-07-01T09:56:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/01/ge-healthcare-and-geron-announce-stem-cell-alliance/ 2009-07-01T10:15:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/01/inovio-biomedical-signs-swine-influenza-a-collaboration-agreement/ 2009-07-01T10:02:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/01/csl-and-talecris-biotherapeutics-terminate-their-merger-agreement/ 2009-07-01T11:02:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/02/morphotek-announces-collaboration-with-synageva-biopharma/ 2009-07-02T10:25:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/02/1393/ 2009-07-02T11:01:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/02/1398/ 2009-07-02T13:32:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/02/scancell-licenses-immunobody-patents-from-merck-serono/ 2009-07-02T13:39:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/02/biogen-idec-and-acorda-therapeutics-announce-collaboration-to-develop-ms-therapy/ 2009-07-02T16:42:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/03/johnson-johnson-takes-takes-over-elan-paartnership-with-wyeth/ 2009-07-03T09:41:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/03/biosante-pharmaceuticals-and-cell-genesys-sign-merger-agreement/ 2009-07-03T09:48:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/06/novartis-commits-to-ten-year-collaboration-with-morphosys/ 2009-07-06T09:15:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/07/wyeth-and-catalyst-biosciences-announce-hemophilia-alliance/ 2009-07-07T09:20:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/07/santherea-cuts-research-staff/ 2009-07-07T09:37:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/08/galapagos-earns-milestone-payment-from-gsk/ 2009-07-08T12:12:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/08/neugenesis-and-path-sign-collaboration-agreement-to-develop-an-influenza-vaccine-production-system/ 2009-07-08T12:11:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/08/alizyme-ceo-steps-down-as-the-company-heads-for-bankruptcy/ 2009-07-13T13:19:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/09/targacept-receive-10-million-milestone-payment-from-astrazeneca/ 2009-07-09T12:54:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/09/map-announces-termination-of-pediatric-asthma-collaboration-with-astrazeneca/ 2009-07-09T13:13:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/10/addex-hits-second-milestone-in-merck-collaboration/ 2009-07-10T12:40:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/10/shanghai-chempartner-and-agios-expand-collaboration/ 2009-07-10T12:52:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/13/novamed-pharmaceuticals-in-licenses-two-new-drugs-for-the-chinese-market/ 2009-07-13T08:55:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/13/merck-and-portola-sign-license-agreement-to-develop-anticoagulant-for-cardiovascular-disease/ 2009-07-13T12:28:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/14/baxter-and-flamel-sign-hemophilia-drug-partnership/ 2009-07-14T08:57:36+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/14/rexahn-pharmaceuticals-licenses-technology-from-krict/ 2009-07-14T09:09:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/14/oscient-files-for-chapter-11/ 2009-07-14T09:35:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/15/abbott-and-gsk-to-collaborate-on-molecular-miagnostic-test/ 2009-07-15T09:59:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/15/innexus-and-genhelix-to-combine-antibody-development-and-manufacturing-resources/ 2009-07-15T10:23:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/15/noven-pharmaceuticals-and-hisamitsu-pharmaceutical-to-merge/ 2009-07-15T11:12:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/15/partnering-profiles-merck-co/ 2009-07-16T10:19:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/16/merck-serono-hooks-up-with-kyowa-hakko-kirin/ 2009-07-16T09:37:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/16/pfizer-enters-not-for-profit-cancer-alliance/ 2009-07-16T10:04:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/16/institute-for-oneworld-health-and-novartis-launch-collaboration-to-combat-diarrheal-disease/ 2009-07-16T09:54:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/16/evotec-announces-research-agreement-with-cubist-pharmaceuticals/ 2009-07-16T10:01:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/16/astrazeneca-and-mental-health-research-institute-in-australia-announce-alzheimers-collaboration/ 2009-07-16T10:03:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/17/gilead-enters-hiv-pill-partnership-with-tibotec/ 2009-07-17T08:58:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/17/champions-biotechnology-partners-with-do-coop-technologies/ 2009-07-17T09:13:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/17/public-private-partnerships-in-the-pharmaceutical-sector/ 2009-07-17T10:23:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/20/alnylam-announces-extension-of-rnai-therapeutics-collaboration-with-novartis/ 2009-07-20T09:15:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/20/exxonmobil-to-fund-600-million-biofuel-partnership-with-synthetic-genomics/ 2009-07-20T09:24:12+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/20/vernalis-receives-milestone-payment-in-hsp90-inhibitor-collaboration/ 2009-07-20T10:49:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/20/skyepharma-signs-settlement-agreement-with-novartis/ 2009-07-20T11:09:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/21/health-care-venture-capital-investments-pass-it-for-the-first-time/ 2009-07-21T06:59:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/21/gilead-and-johnson-johnson-collaborate-to-develop-once-daily-hiv-pill/ 2009-07-21T08:17:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/21/wyeth-terminates-alliance-with-inovio-biomedical/ 2009-07-21T08:20:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/22/osi-pharmaceuticals-and-aveo-pharmaceuticals-expand-oncology-collaboration/ 2009-07-22T08:44:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/22/gsk-and-enigma-diagnostics-announce-commercial-partnership-to-develop-point-of-care-influenza-diagnostics/ 2009-07-22T08:48:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/22/evotec-signs-hts-collaboration-with-alios-biopharma/ 2009-07-22T08:54:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/22/asterand-signs-global-agreement-with-lundbeck/ 2009-07-22T09:14:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/23/alcon-and-astrazeneca-to-collaborate-on-eye-drug-development/ 2009-07-23T09:37:13+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/23/galapagos-achieves-milestone-in-osteoporosis-collaboration-with-lilly/ 2009-07-23T09:51:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/23/glaxosmithkline-completes-acquisition-of-stiefel/ 2009-07-23T09:59:36+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/23/peregrine-pharmaceuticals-licenses-anti-vegf-antibodies-to-affitech/ 2009-07-23T10:21:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/23/biodelivery-sciences-receives-27-million-milestone-payment-from-meda/ 2009-07-23T10:20:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/24/bristol-myers-squibb-to-acquire-medarex/ 2009-07-24T06:51:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/24/microdose-therapeutx-announces-expansion-of-collaboration-with-merck/ 2009-07-24T06:56:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/24/johnson-johnson-terminates-collaboration-with-sunesis/ 2009-07-24T07:00:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/24/galapagos-receives-milestone-in-osteoporosis-collaboration-with-lilly/ 2009-07-24T15:39:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/24/immunomedics-partners-with-alexis-biotech-to-develop-targeted-vaccines/ 2009-07-24T16:06:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/27/miragen-and-archemix-to-collaborate/ 2009-07-27T08:18:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/27/amd-set-to-reorganise-partner-programme/ 2009-07-27T08:25:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/27/sanofi-aventis-to-take-control-of-shantha-biotechnics/ 2009-07-27T08:32:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/27/neogenomics-enters-into-strategic-supply-agreement-with-abbott/ 2009-07-27T18:14:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/28/amgen-to-collaborate-with-glaxosmithkline/ 2009-07-28T07:10:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/28/avila-therapeutics-raises-30-million-financing/ 2009-07-28T07:20:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/28/argolyn-bioscience-files-for-chapter-7/ 2009-07-28T07:26:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/cardiome-achieves-milestone-from-collaboration-with-merck/ 2009-07-29T09:35:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/mvi-and-crucell-collaborate-on-new-malaria-vaccine/ 2009-07-29T09:51:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/raptor-and-torreypines-announce-merger/ 2009-07-29T09:56:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/alizyme-suspends-shares-and-appoints-liquidator/ 2009-07-29T10:08:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/kv-pharmaceutical-hires-bankruptcy-advisor/ 2009-07-29T10:52:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/29/microsoft-and-yahoo-sign-search-partnership/ 2009-07-29T17:24:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/30/pfizer-announces-partnership-with-shanghai-institutes-for-biological-sciences/ 2009-07-30T10:19:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/30/evotec-receives-milestone-payment-from-boehringer-ingelheim/ 2009-07-30T10:24:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/30/forma-therapeutics-announces-collaboration-with-novartis/ 2009-07-30T10:31:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/30/sanofi-aventis-buys-50-stake-in-merial-from-merck/ 2009-07-30T10:49:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/31/ligand-and-organon-terminate-collaboration/ 2009-07-31T06:58:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/31/roche-units-announce-collaboration-with-eli-lilly-and-seqwright/ 2009-07-31T07:05:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/31/micromet-announced-70-million-ipo/ 2009-07-31T11:21:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/31/debiopharm-and-msm-protein-technologies-sign-oncology-alliance/ 2009-07-31T11:31:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/07/31/merck-serono-and-msm-sign-collaboration/ 2009-07-31T11:47:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/neurosearch-announces-alliance-with-janssen/ 2009-08-18T08:14:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/elan-files-declaratory-suit-against-biogen-idec/ 2009-08-18T08:33:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/vernalis-and-glaxosmithkline-enter-into-oncology-collaboration-agreement/ 2009-08-18T08:36:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/dako-enters-collaboration-with-genentech-on-diagnostic-tests-for-patients-with-stomach-cancer/ 2009-08-18T08:39:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/bp-and-martek-biosciences-partner-to-deliver-advanced-biodiesels/ 2009-08-18T08:47:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/18/emd-serono-and-the-md-anderson-cancer-center-announce-collaboration/ 2009-08-18T08:52:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/19/gsk-form-public-private-partnership-in-brazil/ 2009-08-19T09:39:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/19/btg-partner-onyx-triggers-milestone-payment/ 2009-08-19T09:41:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/19/genmab-and-gsk-suffer-trial-setback/ 2009-08-19T12:32:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/20/glaxosmithkline-acquires-influenza-vaccine-manufacturer/ 2009-08-20T12:12:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/20/glenmarks-partnered-drug-fails-in-trials/ 2009-08-20T12:37:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/20/transcept-cuts-staff-on-back-of-alliance/ 2009-08-20T12:40:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/20/nycomed-and-forest-laboratories-to-collaborate-on-daxas/ 2009-08-20T13:23:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/20/durect-announces-asian-license-of-adhd-drug-candidate-to-orient-pharma/ 2009-08-20T13:31:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/21/chemdiv-and-eli-lilly-expand-collaboration/ 2009-08-21T06:35:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/21/partner-healthchecks/ 2009-08-21T13:48:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/24/ucb-and-novartise-sign-german-license/ 2009-08-24T11:50:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/24/medicinova-and-avigen-to-merge/ 2009-08-24T12:07:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/24/astellas-reorganises-research-division/ 2009-08-24T12:14:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/24/santhera-signs-dela-with-biovail/ 2009-08-24T12:20:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/25/shire-signs-deal-with-santaris/ 2009-08-25T08:26:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/25/simcere-pharmaceutical-collaborates-with-sun-yat-sen-university-cancer-center/ 2009-08-25T08:28:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/25/wyeth-takes-over-karo-bio-collaboration/ 2009-08-25T08:38:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/25/warner-chilcott-to-buy-procter-gambles-pharmaceuticals-business/ 2009-08-25T09:04:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/26/ligand-to-acquire-neurogen/ 2009-08-26T08:36:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/26/profectus-biosciences-signs-collaboration-with-the-path-malaria/ 2009-08-26T08:54:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/26/fast-forward-and-amplimmune-ink-ms-alliance/ 2009-08-26T08:57:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/26/are-european-drug-makers-more-innovative-than-us-companies/ 2009-08-26T09:01:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/27/prostrakan-partners-with-endo-for-fortigel-in-the-usa/ 2009-08-27T10:52:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/27/phylogica-close-to-announcing-partnership/ 2009-08-27T11:07:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/27/endocyte-earns-milestone-from-bms/ 2009-08-27T11:46:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/28/silence-therapeutics-signs-sirna-delivery-collaboration-with-dainippon-sumitomo-pharma/ 2009-08-28T09:00:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/28/btg-sels-hysolv-to-novartis-for-up-to-10-million/ 2009-08-28T09:08:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/08/28/abbott-to-collaborate-with-pfizer-inc-on-companion-diagnostic-tes/ 2009-08-28T09:24:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/01/nuevolution-announces-research-collaboration-with-novartis/ 2009-09-01T09:26:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/01/facet-biotech-and-trubion-partner-to-develop-tru-016/ 2009-09-01T09:30:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/02/ucb-and-novartis-expand-alliance-in-germany/ 2009-09-02T09:55:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/02/metabasis-therapeutics-ceo-joins-merck/ 2009-09-02T10:09:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/02/sony-snubs-microsoft-in-favour-of-google-chrome/ 2009-09-02T10:17:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/02/psychogenics-and-astrazeneca-enter-cns-agreement/ 2009-09-02T10:26:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/pct-signs-collaboration-with-roche/ 2009-09-03T10:47:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/dxs-enters-into-collaboration-with-bristol-myers-squibb-and-imclone-systems/ 2009-09-03T10:28:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/bioms-and-eli-lilly-terminate-dirucotide-collaboration/ 2009-09-03T10:40:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/leo-pharma-to-buy-peplin-for-288-million/ 2009-09-03T11:32:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/dainippon-sumitomo-to-acquire-sepracor-for-2-6-billion/ 2009-09-03T12:25:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/03/king-pharma-terminates-idea-ag-partnership/ 2009-09-03T12:38:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/04/court-rules-that-elan-breached-biogen-partnership/ 2009-09-04T09:41:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/04/algeta-signs-800-million-partnership-with-bayer/ 2009-09-04T10:39:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/07/pharma-groups-to-focus-on-alliances/ 2009-09-07T08:51:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/07/biogen-makes-a-bid-for-facet-biotech/ 2009-09-07T09:20:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/07/ipsen-and-debiopharm-sign-exclusive-worldwide-license-agreement/ 2009-09-07T09:39:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/08/seattle-genetics-achieves-milestone-in-bayer-schering-collaboration/ 2009-09-08T16:46:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/08/suven-gets-first-milestone-from-eli-lilly-collaboration/ 2009-09-08T16:49:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/08/galenica-buys-om-pharma/ 2009-09-08T17:09:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/09/cell-biosciences-buys-alpha-innotech/ 2009-09-09T10:41:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/09/meda-and-cipla-extend-collaboration/ 2009-09-09T10:47:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/09/genzyme-shares-trade-lower-on-failure-of-partnered-drug/ 2009-09-09T10:53:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/09/evotec-announces-research-agreement-with-biogen-idec/ 2009-09-09T10:58:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/10/xoma-signs-6-million-collaboration-with-arana-therapeutics/ 2009-09-10T09:06:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/10/arpida-and-evolva-set-to-merge/ 2009-09-10T09:13:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/10/prana-biotechnology-raises-a6-million/ 2009-09-10T09:15:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/10/methylgene-and-otsuka-pharmaceutical-extend-collaboration/ 2009-09-10T09:18:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/11/amylin-and-biocon-sign-diabetes-partnership/ 2009-09-11T11:02:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/11/champions-biotechnology-partners-with-pinnaclecare/ 2009-09-11T11:44:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/11/inserm-transfert-and-innate-pharma-sign-research-partnership/ 2009-09-11T11:51:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/14/alcon-to-acquire-esbatech/ 2009-09-14T08:29:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/14/neuronascent-and-chemdiv-sign-services-deal/ 2009-09-14T10:23:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/14/jonhson-johnson-seeks-elan-cut/ 2009-09-14T13:11:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/15/elan-cures-tysabri-breach/ 2009-09-16T10:46:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/15/genova-biotherapeutics-signs-collaboration-agreement-with-bridge-bioresearch/ 2009-09-15T09:09:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/15/abd-serotec-and-find-sign-research-collaboration-agreement/ 2009-09-15T09:12:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/15/pieris-enters-into-anticalin-collaboration-with-allergan/ 2009-09-15T09:18:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/16/genova-biotherapeutics-signs-collaboration-agreement-with-prime-bioresearch/ 2009-09-16T10:51:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/16/almac-and-lilly-partner-on-companion-diagnostic-development/ 2009-09-16T11:00:12+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/16/sanofi-aventis-and-regeneron-pharmaceuticals-ending-phase-iii-trial-of-aflibercept/ 2009-09-16T11:13:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/17/galapagos-charleys-fund-and-the-nash-avery-foundation-partner-on-duchenne-muscular-dystrophy-target/ 2009-09-17T09:25:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/17/keryx-biopharma-receives-fda-orphan-drug-designation-for-perifosine/ 2009-09-17T09:27:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/17/polytherics-and-minapharm-pharmaceuticals-sign-collaboration-agreement/ 2009-09-17T09:30:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/18/wellcome-trust-and-merck-launch-vaccine-joint-venture/ 2009-09-18T09:45:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/18/genova-biotherapeutics-and-korean-university-sign-partnership-agreement/ 2009-09-18T10:01:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/18/karo-licences-thyroid-hormone-receptor-patent-from-pfizer/ 2009-09-18T10:05:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/21/nycomed-makes-a-bid-for-solvay/ 2009-09-21T08:47:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/21/wyeth-and-ambrx-form-multi-target-alliance/ 2009-09-21T09:17:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/21/genova-signs-collaboration-agreement-with-beckpharma/ 2009-09-21T09:20:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/21/renovo-announces-restructuring/ 2009-09-21T10:04:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/22/astrazeneca-and-nektar-sign-worldwide-collaboration-agreement-worth-up-to-735-million/ 2009-09-22T08:52:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/22/xoma-faces-delisting-threat/ 2009-09-22T09:04:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/22/icagen-collaboration-with-pfizer-extended/ 2009-09-22T09:10:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/23/selexis-and-neogenix-oncology-enter-into-research-services-agreement/ 2009-09-23T09:05:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/23/celera-and-medco-enter-research-collaboration/ 2009-09-23T09:17:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/abbott-reported-to-have-made-a-bid-for-solvays-drugs-unit/ 2009-09-24T09:31:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/galapagos-announces-expanded-drug-discovery-collaboration-with-schering-plough/ 2009-09-24T09:36:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/opexa-therapeutics-triggers-novartis-milestone-payment/ 2009-09-24T09:39:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/xoma-shares-rise-on-antibody-research-contract/ 2009-09-24T09:45:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/karus-therapeutics-and-queen-mary-university-of-london-announce-pi3-kinase-collaboration/ 2009-09-24T10:02:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/24/merck-and-qiagen-collaborate-on-hpv-access/ 2009-09-24T10:06:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/25/lpath-and-merck-serono-extend-asonep-collaboration/ 2009-09-25T11:13:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/25/xoma-falls-back-into-the-delisting-zone/ 2009-09-25T11:17:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/25/sigma-tau-invests-in-dor-biopharma/ 2009-09-25T11:20:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/25/eisai-ammends-aricept-partnership-with-pfizer/ 2009-09-25T11:26:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/28/abbott-buys-solvays-drug-unit-for-6-6-billion/ 2009-09-28T10:26:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/28/biofocus-expands-collaboration-with-schering-plough/ 2009-09-28T10:30:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/28/johnson-johnson-and-crucell-sign-mab-collaboration/ 2009-09-28T10:36:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/28/qrxpharma-ties-up-with-liaoning-nuokang-medicines-co/ 2009-09-28T10:39:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/29/ucb-and-astrazeneca-form-alliance-for-the-commercialization-of-cimzia-in-brazil/ 2009-09-29T09:13:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/29/glaxo-signs-vaccine-deal-with-brazil/ 2009-09-29T09:25:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/30/lupin-acquires-the-us-rights-for-antara/ 2009-09-30T06:41:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/30/gsk-and-kaketsuken-to-co-develop-eb66-cell-based-flu-vaccines/ 2009-09-30T06:47:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/30/palatin-technologies-earns-5-million-payment-from-astrazeneca/ 2009-09-30T06:49:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/30/asap-biopharma-alliance-fall-conference-program-announced/ 2009-09-30T08:39:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/09/30/positive-research-data-fails-to-push-xoma-above-delisting-zone/ 2009-09-30T13:54:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/xoma-announces-14-million-financing/ 2009-10-01T10:14:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/silence-therapeutics-in-merger-talks/ 2009-10-01T10:13:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/sanofi-aventis-enters-license-agreement-with-merrimack/ 2009-10-01T08:50:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/evotec-achieves-milestone-with-cardioxyl-pharmaceuticals/ 2009-10-01T08:48:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/ablynx-achieves-second-milestone-in-its-collaboration-with-wyeth/ 2009-10-01T09:25:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/alpharx-enters-alliance-with-riso-pharma-tech-to-develop-wound-treatment/ 2009-10-01T09:55:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/01/aeterna-zenaris-and-keryx-biopharmaceuticals-announce-promising-clinical-trial-results-for-joint-cancer-drug/ 2009-10-01T10:12:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/02/ablynx-receives-second-milestone-payment-from-boehringer-ingelheim/ 2009-10-02T10:27:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/02/general-electric-investigating-partnership-or-ipo-for-its-nbc-universal-unit/ 2009-10-02T11:06:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/02/checkorphan-and-getreel-health-technology-partnership/ 2009-10-02T11:12:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/05/vertex-sells-forward-future-telaprevir-milestone-payments/ 2009-10-05T10:50:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/05/cyberonics-announces-epilepsy-technology-collaborations/ 2009-10-05T10:59:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/05/roche-using-snalps-with-first-rnai-rx-candidate/ 2009-10-05T11:01:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/bausch-lomb-announces-acquisition-of-tubilux-pharmas-commercial-asse/ 2009-10-06T08:31:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/theraclone-and-zenyaku-sign-alliance-for-mabs-against-flu/ 2009-10-06T08:43:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/fovea-pharmaceuticals-to-be-acquired-by-sanofi-aventis/ 2009-10-06T08:38:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/salix-pharmaceuticals-acquires-us-right-to-lupins-bioadhesive-technology/ 2009-10-06T08:47:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/inviragen-and-singvax-merge-vaccine-pipelines/ 2009-10-06T08:50:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/cytopia-merges-with-toronto-based-ym-biosciences/ 2009-10-06T08:58:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/06/glaxosmithkline-and-jiangsu-walvax-biotech-enter-partnership-for-paediatric-vaccines/ 2009-10-06T09:30:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/07/var-vistrom-and-citrix-partnership/ 2009-10-07T12:56:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/07/delsitech-and-orion-corporation-drug-delivery-collaboration/ 2009-10-07T13:00:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/07/galapagos-reaches-first-milestone-in-alliance-with-glaxosmithkline/ 2009-10-07T13:28:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/ablynx-achieves-second-milestone-in-alliance-with-novartis/ 2009-10-08T09:18:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/partnering-profiles-glaxosmithkline/ 2009-10-16T12:43:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/ipsen-and-spirogen-restructure-anticancer-allaince/ 2009-10-08T09:44:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/novartis-gains-exclusive-worldwide-rights-to-ptk-0796/ 2009-10-08T09:51:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/sosei-assigns-pain-drug-assets-to-pharmasol/ 2009-10-08T09:56:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/amarillo-biosciences-and-intas-pharmaceuticals-sign-influenza-alliance/ 2009-10-08T10:01:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/08/making-sense-of-partner-feedback-requires-attention-to-biases/ 2009-10-09T10:33:13+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/09/inviragen-and-singvax-merge-vaccine-pipelines-2/ 2009-10-09T10:06:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/09/alliance-between-gvk-biosciences-and-quantitative-solutions/ 2009-10-09T10:32:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/09/ipsen-and-braintree-laboratories-partner-for-colorectal-cancer-treatment/ 2009-10-09T10:42:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/09/saic-and-bplg-form-technology-alliance/ 2009-10-09T11:11:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/09/labopharm-and-grunenthal-sign-distribution-and-supply-agreement/ 2009-10-09T11:15:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/12/ac-immune-and-bayer-collaborate-in-brain-imaging-for-alzheimer%e2%80%99s-disease/ 2009-10-12T08:22:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/12/locus-pharmaceuticals-signs-discovery-research-collaboration-with-novartis/ 2009-10-12T08:31:00+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/12/does-social-network-analysis-have-any-place-in-alliance-management/ 2009-10-13T08:15:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/13/heptares-sign-a-200-million-deal-with-novartissigns/ 2009-10-14T09:59:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/13/vanda-pharmaceuticals-signs-agreement-with-novartis/ 2009-10-13T11:36:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/13/sinclair-buys-solvay-dermatology-drugs/ 2009-10-13T11:42:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/13/orion-genomics-enters-discovery-collaboration-with-novartis/ 2009-11-02T09:17:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/14/prosensa-and-gsk-sign-duchenne-muscular-dystrophy-partnership/ 2009-10-14T07:45:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/14/roche-appoints-joe-mccracken-as-head-of-pharma-partnering-asia/ 2009-10-14T07:48:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/14/shire-and-sandoz-settle-all-adderall-pending-litigation/ 2009-10-14T08:00:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/14/sosei-assigns-sd1-to-biocopea/ 2009-10-14T08:05:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/15/galapagos-expands-alliance-with-merck-co-for-atherosclerosis-drugs/ 2009-10-15T08:58:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/15/xoma-appoints-new-alliance-manager/ 2009-10-15T09:13:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/15/monoclonal-antibodies-the-hotspot-for-alliances-and-mergers-and-acqusitions/ 2009-10-20T09:40:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/15/does-the-notion-of-trust-have-any-place-in-alliance-metrics/ 2009-10-16T09:18:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/15/partnering-profiles-astrazeneca/ 2009-10-19T13:07:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/second-alliance-between-graffinity-pharmaceuticals-and-genentech/ 2009-10-16T08:45:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/alliance-between-merck-kgaa-and-dyesol-limited/ 2009-10-16T09:32:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/technology-platform-collaboration-between-statmon-technologies-corporation-and-digital-nirvana-inc/ 2009-10-16T09:39:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/collaboration-between-digi-data-corporation-and-hitachi-data-systems/ 2009-10-16T09:46:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/alliance-between-amdl-diagnostics-and-cetecancer/ 2009-10-16T09:49:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/alliance-between-capgemini-and-microsoft/ 2009-10-16T09:54:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/evotec-and-ono-pharmaceutical-extend-their-collaboration/ 2009-10-16T10:33:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/amplimmune-and-nationcal-cancer-institute-start-alliance/ 2009-10-16T10:08:11+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/16/compugen-and-bayer-schering-pharma-antibody-alliance/ 2009-10-16T10:17:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/19/biogen-idec-and-biovitrum-ab-alliance-launches-trial/ 2009-10-19T09:30:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/19/kyorin-and-eisai-sign-licensing-agreement-for-uritos/ 2009-10-19T10:06:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/19/kinaxo-biotechnologies-and-bayer-vital-gmbh-collaborate/ 2009-10-20T12:27:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/alliance-between-morphosys-and-daiichi-sankyo-for-treatment-for-hospital-acquired-infections/ 2009-10-20T09:20:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/alliance-between-hyrdra-biosciences-and-cubist-pharmaceuticals/ 2009-10-20T11:16:12+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/milestone-payment-for-human-genome-sciences-from-novartis/ 2009-10-20T10:09:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/xilinx-and-arm-in-platform-alliance/ 2009-10-20T10:19:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/pharmaceutical-distribution-alliance-between-mitsibishi-corporation-medipal-holdings-corporation-and-sinopharm/ 2009-10-20T10:26:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/ge-healthcare-partnership-with-etisalat/ 2009-10-20T10:41:40+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/20/semi-conductor-alliance-between-nxp-and-virage-logic/ 2009-10-20T11:11:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/alliance-between-novavax-and-xcellerex-for-h1n1-vaccine/ 2009-10-21T12:58:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/feasibility-partnership-between-gamida-cell-and-cellerix/ 2009-10-21T13:09:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/collaboration-between-kinaxo-and-roche/ 2009-10-21T13:13:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/wellstat-therapeutics-and-sanofi-aventis-insulin-alliance-for-type-ii-diabetes/ 2009-10-21T13:19:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/cochlear-limited-and-nxp-semiconductors-collaborate-on-hearing-implants/ 2009-10-21T13:32:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/2352/ 2009-10-21T13:41:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/ipsen-grants-license-to-menarini-for-gout-treatment/ 2009-10-21T13:46:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/agreement-between-simcere-and-osi-pharmaceuticals/ 2009-10-21T14:01:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/21/origene-technologies-acquires-marligen-biosciences/ 2009-10-21T14:03:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/22/evotec-achieves-seventh-milestone-in-alliance-with-boehringer-ingelheim/ 2009-10-22T09:07:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/22/alliance-between-roche-and-high-throughput-genomics-for-gene-expression-applications/ 2009-10-22T09:12:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/22/protein-discovery-and-new-objective-partner-for-protein-analysis-applications/ 2009-10-22T09:22:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/22/technology-alliance-between-tableau-software-and-teradata/ 2009-10-22T09:31:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/22/technology-alliance-between-casecentral-and-storediq/ 2009-10-22T09:34:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/23/theravance-receives-milestone-payment-from-astellas/ 2009-10-23T09:28:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/23/evotec-receives-e2-5-million-milestone-from-boehringer-ingelheim/ 2009-10-23T11:36:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/23/bms-ceo-looks-to-partnerships/ 2009-10-23T11:40:30+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/23/yissum-signs-research-collaboration-with-roche/ 2009-10-23T12:31:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/26/supergen-signs-collaboration-with-glaxosmithkline/ 2009-10-26T13:54:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/26/eisai-and-tsd-japan-partner-on-denileukin-diftitox-in-japan/ 2009-10-26T14:03:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/26/itochu-invests-in-mpm-biotechnology-fund/ 2009-10-26T14:09:26+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/27/biomarin-pharmaceutical-announces-the-acquisition-of-huxley-pharmaceuticals/ 2009-10-27T11:24:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/27/champions-biotechnology-expands-collaboration-with-johnson-johnson/ 2009-10-27T11:26:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/27/gsk-and-genmab-receive-accelerated-approval-for-arzerra/ 2009-10-27T11:55:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/27/scynexis-receives-milestone-from-merck-co/ 2009-10-27T13:47:50+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/28/cephalon-get-option-to-purchase-bioassets-development-corporation/ 2009-10-28T12:55:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/28/ppd-invests-100-million-in-celtic-therapeutics-holdings/ 2009-10-28T13:03:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/28/pfizer-reported-to-be-shopping-for-deals-in-india/ 2009-10-28T13:06:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/28/ligand-to-acquire-metabasis/ 2009-10-28T13:11:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/29/sanofi-aventis-and-micromet-collaborate-on-bite-antibody/ 2009-12-01T13:26:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/29/taspoglutide-meets-its-primary-endpoint-in-phase-iii-trial/ 2009-10-29T10:38:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/29/johnson-johnson-wants-more-collaborations/ 2009-10-29T11:06:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/30/aryx-therapeutics-restructures-pending-licensing-deal/ 2009-10-30T10:40:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/10/30/eisai-and-quintiles-partner-to-develop-eisais-anticancer-compounds/ 2009-10-30T10:43:17+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/02/valuing-collaboration/ 2009-11-02T09:34:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/02/amicus-therapeutics-and-shire-end-genetic-partnership/ 2009-11-02T18:38:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/alliance-between-quintiles-and-astrazeneca/ 2009-11-03T08:52:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/proximagen-neuroscience-acquires-cambridge-biotechnology-ltd-and-certain-biovitrum-programmes/ 2009-11-03T09:05:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/licensing-agreement-between-surmodics-and-nupath/ 2009-11-03T10:09:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/neostem-acquires-china-biopharmaceuticals/ 2009-11-03T10:17:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/distribution-agreement-between-broncus-technologies-and-medico-hirata/ 2009-11-03T10:26:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/marketing-partnership-between-openx-and-microsoft/ 2009-11-03T10:36:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/parnership-between-attunity-and-microsoft/ 2009-11-03T10:40:35+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/alliance-between-endotis-pharma-and-catalent-pharma-solutions/ 2009-11-03T10:47:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/alliance-between-sanofi-aventis-and-micromet/ 2009-11-03T10:51:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/alliance-between-orion-genomics-and-novartis-pharma-ag/ 2009-11-03T10:58:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/abbott-acquires-medical-devices-company-evalve-inc/ 2009-11-03T13:26:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/03/xoma-signs-alliance-with-kaketsuken/ 2009-11-03T13:37:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/04/monoclonal-alliance-between-human-genome-sciences-and-glaxosmithkline-proving-positive/ 2009-11-04T13:52:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/04/monoclonal-antibody-distribution-alliance-between-quotient-biodiagnostics-and-med-alliance-group/ 2009-11-04T13:43:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/04/milestone-payment-for-biocryst-from-shionogi-for-influenza-drug/ 2009-11-04T13:49:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/09/partnering-profile-novartis/ 2009-11-09T11:46:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/novartis-acquires-85-stake-in-zhejiang-tianyuan-bio-pharmaceutical/ 2009-11-10T09:42:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/evotec-and-boehringer-ingelheim-expand-alliance/ 2009-11-10T09:27:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/termination-agreement-between-micromet-and-medimmune/ 2009-11-10T09:38:56+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/platform-alliance-between-zeomega-and-eldorado-computing/ 2009-11-10T09:53:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/pfizer-and-ligand-extend-alliance/ 2009-11-10T09:58:21+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/10/licensing-agreement-between-tapimmune-and-crucell/ 2009-11-10T10:14:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/11/sanofi-aventis-and-regeneron-pharmaceuticals-extend-monoclonal-antibody-alliance/ 2009-11-11T13:08:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/11/sanofi-aventis-interested-in-setting-up-venture-capital-fund-to-promote-strategic-partnerships/ 2009-11-11T13:17:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/11/hoffman-la-roche-and-sri-international-collaborate-on-neurological-and-psychiatric-conditions/ 2009-11-11T13:20:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/11/alliance-between-spectrum-pharmaceuticals-and-nippon-kayaku/ 2009-11-11T13:43:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/11/collaboration-between-d-pharm-and-wanbang-biopharmaceuticals/ 2009-11-11T13:54:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/12/alliance-between-eindhoven-and-stmelectronics/ 2009-11-12T12:24:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/12/alliance-struck-between-bristol-myers-squibb-and-alder-biopharmaceuticals-worth-us1-billion/ 2009-11-12T12:55:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/13/pangentics-licenses-antibody-to-abbott/ 2009-11-13T09:16:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/13/glaxosmithkline-alliance-with-astex-therapeutics/ 2009-11-13T09:24:39+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/16/biota-acquires-antibacterial-assets-from-prolysis/ 2009-11-16T12:01:31+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/16/bioinvent-and-daiichi-sankyo-sign-licensing-and-discovery-agreement/ 2009-11-16T12:10:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/16/genzyme-corporation-and-to-bbb-partner-to-develop-drugs-to-penetrate-brain-barrier/ 2009-11-16T12:18:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/17/novartis-partners-with-sarawak-biodiversity-centre-and-malaysian-biotech-corporation/ 2009-11-17T09:53:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/17/glaxosmithkline-and-nabi-biopharmaceuticals-partner-for-nicotine-addition-vaccine/ 2009-11-17T10:26:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/18/glaxosmithkline-and-biomerieux-partner-for-predictive-breast-cancer-test/ 2009-11-19T12:40:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/perkinelmer-and-gilson-partner-to-improve-mass-spectroscopy/ 2009-11-19T09:12:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/partnership-between-eragen-biosciences-and-illumina/ 2009-11-19T09:18:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/alliance-between-champions-biotechnology-yale-university-and-southern-research-institute/ 2009-11-19T09:26:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/decode-genetics-files-for-bankruptcy/ 2009-11-19T09:43:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/ablynx-receives-third-milestone-payment-from-novartis/ 2009-11-19T09:52:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/ge-health-and-fujifilm-launch-product-5-months-after-start-of-alliance/ 2009-11-19T10:13:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/19/partnering-profiles-amgen/ 2009-11-19T15:54:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/20/ligand-receives-2-million-milestone-payment-from-merck-co/ 2009-11-20T10:11:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/20/biomarker-alliance-between-rules-based-medicine-and-covance/ 2009-11-20T10:20:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/20/hra-pharma-and-acrux-partner-to-market-transdermal-estradiol-spray-for-menopause-symptoms/ 2009-11-20T10:36:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/20/jennerex-and-lees-pharmaceutical-holdings-partner-to-jx-594/ 2009-11-20T10:53:28+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/20/innate-pharma-and-celgene-collaborate-on-clinical-trial-of-lenalidomide/ 2009-11-20T12:19:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/23/glaxosmithkline-enters-joint-ventures-to-combat-h1n1-flu/ 2009-11-23T10:07:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/23/novartis-and-horizon-discovery-collaborate-on-cancer-models/ 2009-11-23T10:10:05+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/seattle-genetics-and-agensys-expand-antibody-collaboration/ 2009-11-24T11:16:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/clavis-pharma-and-clovis-oncology-partner-to-develop-drug-for-cancer/ 2009-11-24T11:24:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/novartis-and-us-department-of-health-and-human-services-partner-to-establish-cell-culture-influenza-vaccine-manufacturing-facility/ 2009-11-24T11:39:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/spectrum-pharmaceuticals-and-handok-sign-alliance-for-apaziquone/ 2009-11-24T12:58:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/bristol-myers-quibb-extends-collaboration-with-asterand/ 2009-11-26T14:06:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/24/partnering-profile-bristol-myers-squibb/ 2009-11-26T14:04:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/25/gilead-sciences-and-glaxosmithkline-enter-licensing-agreement-for-hepatitis-b-treatment/ 2009-11-25T11:17:06+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/25/novartis-and-incyte-enter-licensing-agreement-for-blood-disorders-and-cancer-drugs/ 2009-11-25T11:29:16+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/25/jubilant-organosys-university-of-alabama-and-southern-research-institute-start-joint-venture/ 2009-11-25T11:36:42+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/25/isi-and-pharma-to-market-enter-software-partnership/ 2009-11-25T11:40:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/25/agreement-between-micromet-and-lonza-for-antibody-for-hematologic-cancers/ 2009-11-25T11:45:53+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/26/merck-co-launches-phase-ii-trial-for-karo-bios-drug/ 2009-11-26T09:51:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/26/novartis-and-idera-to-end-researach-collaboration-for-asthma-and-allergy-treatments/ 2009-11-26T10:00:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/26/merck-co-extend-partnership-with-idera/ 2009-11-26T10:08:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/26/biovitrium-sells-cambridge-biotechnology-ltd-to-proximagen-neuroscience/ 2009-12-01T13:52:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/26/pfizer-acquires-stem-cell-therapy-assets-from-axordia/ 2009-11-26T10:29:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/27/resarch-collaboration-between-oxford-expression-technologies-paratechs-and-lifesensors/ 2009-11-27T09:28:55+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/27/partnering-profile-eli-lilly/ 2009-11-27T15:03:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/30/partnering-profiles-sanofi-aventis/ 2009-12-01T07:50:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/30/sanofi-aventis-and-intelliject-partner-for-anaphalaxis-injector/ 2009-11-30T14:59:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/11/30/xomas-nasdaq-delisting-saga-continues/ 2009-11-30T19:24:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/01/bayer-schering-and-micromet-to-develop-new-antibody-for-solid-tumours/ 2009-12-01T13:32:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/01/jubilant-organosys-and-eli-lilly-extend-drug-discovery-collaboration/ 2009-12-01T13:49:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/01/amgen-expands-kineret-license-to-biovitrum/ 2009-12-01T13:55:38+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/02/addex-and-merck-co-extend-research-collaboration/ 2009-12-02T12:34:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/02/technology-alliance-between-esterel-technologies-and-quantum3d/ 2009-12-02T12:36:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/02/galenea-and-otsuka-extend-their-research-and-development-collaboration-for-schizophrenia-and-cns-disorders/ 2009-12-02T12:40:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/02/codexis-and-teva-expand-collaboration/ 2009-12-02T14:21:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/02/partnering-profile-daiichi-sankyo/ 2009-12-03T11:18:25+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/noxxon-receives-milestone-payment-from-eli-lilly/ 2009-12-03T11:50:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/astrazeneca-and-targacept-in-alliance-to-treat-depression/ 2009-12-03T11:59:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/ablynx-receives-third-milestone-payment-from-boehringer-ingelheim/ 2009-12-03T12:02:54+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/sanofi-aventis-enters-licensing-agreement-with-rockefeller-university/ 2009-12-03T12:06:45+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/galapagos-achieves-multiple-milestones-in-rheumatoid-arthritis-alliance-with-janssen-pharmaceutica/ 2009-12-03T12:22:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/diabetes-agreement-between-phenomix-and-chiesi/ 2009-12-03T12:34:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/03/partnering-profile-eisai/ 2009-12-03T16:13:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/04/raytheon-licenses-digital-mamography-technology-to-fujifilm/ 2009-12-04T14:25:59+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/04/roche-and-psynova-neurotech-partnership-for-schizophrenia-diagnostics/ 2009-12-04T14:29:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/04/bioinformatics-alliance-between-aditi-technologies-and-microsoft-bioit-alliance/ 2009-12-04T14:37:29+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/04/alliance-between-ibt-bebig-and-core-oncology/ 2009-12-04T15:03:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/08/roche-terminates-s1p1-alliance-with-actelion/ 2009-12-08T10:16:41+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/08/galapagos-receives-milestone-in-glaxosmithkline-alliance/ 2009-12-08T09:49:15+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/08/la-jolla-pharmaceutical-enters-into-merger-agreement-with-adamis-pharmaceuticals/ 2009-12-08T10:26:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/09/pfizer-and-crown-bioscience-announce-cancer-collaboration/ 2009-12-09T10:05:49+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/09/tranzyme-pharma-signs-discovery-collaboration-with-bms/ 2009-12-09T10:25:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/09/lilly-renews-partnership-with-applied-neurosolutions/ 2009-12-09T10:34:46+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/09/manufacturing-and-supply-alliance-between-generex-and-sanofi-aventis/ 2009-12-16T11:22:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/09/pfizer-looks-to-boost-its-business-through-copied-biotechnology-drugs/ 2009-12-16T11:32:37+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/10/sanofi-aventis-signs-partnership-with-caltech/ 2009-12-10T14:44:33+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/10/cytokinetics-and-gks-terminate-oncology-alliance/ 2009-12-10T14:50:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/10/nabi-earns-5-million-milestone-payment-from-glaxosmithkline/ 2009-12-10T14:55:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/10/astrazeneca-and-biocompatibles-to-initiate-diabetes-study/ 2009-12-10T14:59:14+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/11/genentech-terminates-sgn-40-alliance-with-seattle-genetics/ 2009-12-11T14:49:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/11/gsk-takes-stake-in-intercell/ 2009-12-11T14:52:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/14/evotec-receives-milestone-from-its-collaboration-with-ono-pharmaceutical/ 2009-12-14T13:35:47+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/14/ym-biosciences-and-biotechnology-research-institute-announce-collaborations-first-results/ 2009-12-14T13:37:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/14/third-collaboration-between-novacta-therapeutics-and-o2h/ 2009-12-14T13:43:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/14/innexus-biotechnology-and-xeris-pharmaceuticals-enter-partnership/ 2009-12-14T13:46:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/monoclonal-antibody-alliance-between-seattle-genetics-and-millennium-takeda/ 2009-12-15T10:01:24+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/array-biopharma-and-amgen-partner-for-type-2-diabetes-programme/ 2009-12-15T10:04:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/research-collaboration-between-rexahn-pharmaceuticals-and-theratarget/ 2009-12-15T10:19:27+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/monoclonal-antibody-licensing-agreement-between-sanofi-aventis-and-alopexx-pharmaceuticals/ 2009-12-15T10:45:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/collaboration-between-clarient-and-bioview-for-lung-cancer-diagnostic-test/ 2009-12-15T10:50:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/15/monoclonal-antibody-license-between-medimmune-and-trelis-bioscience/ 2009-12-15T11:28:22+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/16/glaxo-and-galapagos-further-expand-arthritis-alliance/ 2009-12-16T10:53:08+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/16/cisco-and-accenture-extend-their-alliance/ 2009-12-16T10:55:34+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/16/astrazeneca-and-university-of-virginia-start-strategic-collaboration-for-coronoary-artery-disease/ 2009-12-16T11:00:51+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/16/advaxis-and-national-cancer-institute-collaborate-in-cervical-cancer-clinical-trial/ 2009-12-16T11:09:48+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/16/astrazeneca-in-hunt-for-alliances/ 2009-12-16T13:05:02+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/17/ipsens-partner-roche-announces-that-taspoglutide-meets-its-primary-endpoints/ 2009-12-17T10:41:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/17/almirall-and-forest-laboratories-expand-respiratory-collaboration/ 2009-12-17T10:45:32+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/17/ethicon-and-acclarent-announce-merger-agreement/ 2009-12-17T10:48:20+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/17/nanobio-licenses-cold-sore-treatment-to-gsk/ 2009-12-17T10:55:52+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/18/eisai-to-buy-akarx/ 2009-12-18T08:49:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/18/ambit-biosciences-and-astellas-pharma-sign-flt3-partnership/ 2009-12-18T08:55:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/18/bioms-invests-in-spectral-diagnostics/ 2009-12-18T09:32:09+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/18/vion-pharmaceuticals-files-for-chapter-11/ 2009-12-18T09:37:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/21/gsk-buys-stake-in-jcr-pharmaceuticals/ 2009-12-21T08:25:18+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/21/advaxis-partners-with-national-cancer-institute-group/ 2009-12-21T08:30:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/21/btg-licenses-relgel-to-allergan/ 2009-12-21T08:46:19+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/21/roche-and-takara-bio-sign-licensing-agreement/ 2009-12-21T08:55:07+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/sanofi-aventis-buys-chattem-for-1-9-billion/ 2009-12-22T07:54:03+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/clarient-announces-acquisition-of-applied-genomics/ 2009-12-22T07:58:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/merck-agrees-to-buy-avecia-biologics/ 2009-12-22T08:02:57+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/abbott-to-acquire-starlims-technologies-for-123-million/ 2009-12-22T08:09:58+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/seattle-genetics-to-collaborate-with-glaxosmithkline-on-antibody-drugs/ 2009-12-22T08:13:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/22/teva-signs-drug-development-deal-with-oncogenex/ 2009-12-22T08:19:10+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/bayer-returns-recothrom-rights-to-zymogenetics/ 2009-12-23T07:47:04+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/%c3%a6terna-zentaris-announces-termination-of-agreement-with-sanofi-aventis/ 2009-12-23T07:50:44+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/actelion-reports-arbitration-results-between-cotherix-and-asahi-kasei/ 2009-12-23T07:55:23+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/applied-neurosolutions-increases-scope-of-lilly-partnership/ 2009-12-23T07:58:43+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/astrazeneca-buys-the-rights-to-biovitrum-leptin-modulator-programme/ 2009-12-23T08:02:01+00:00 weekly 0.6 http://silico.wordpress.com/2009/12/23/xoma-removes-going-concern-qualification/ 2009-12-23T13:15:00+00:00 weekly 0.6 http://silico.wordpress.com/ 2009-12-23T13:15:00+00:00 daily 1.0